EPD Technologies Pty Ltd specializes in Electronic Pathogen Detection (EPD), a groundbreaking method for identifying pathogens in vivo. This technique is non-invasive, rapid, safe, and can be performed remotely, significantly enhancing the safety of healthcare and laboratory workers.

Key Features:
Non-invasive and Rapid: EPD can diagnose pathogens quickly and painlessly, providing results in a short time frame without the need for invasive procedures.
Remote Capability: This technology allows minimal contact with patients or animals, reducing the risk of infection spread and enhancing safety.
Electronic PCR Analogy: EPD functions similarly to traditional PCR blood tests but operates electronically, streamlining the diagnostic process.
Applications and Impact:
Veterinary Medicine: EPD has shown remarkable results in veterinary applications and is currently undergoing pilot studies to further validate its efficacy.
Human Medicine: Since 2010, observational evidence supports EPD's accuracy in diagnosing pathogens in human patients.
COVID-19 Response: EPD can play a critical role in widespread, cost-effective testing, crucial for managing pandemics by enabling rapid and accurate diagnostics.
Company Background:
Founded by Dr. Ilse Erasmus, Henning Els, and Jacques Steyn, EPD Technologies has spent the past decade developing and refining this technology to detect a variety of pathogens using specialized electronic equipment.

Research and Development:
Current Studies: The company is collaborating with the Veterinary School of the University of Pretoria to validate EPD's accuracy in veterinary practice.
Data and AI Integration: EPD Technologies employs advanced scientific methods, artificial intelligence, and cloud-based analysis to deliver diagnostic results in 10-15 minutes, ensuring swift and reliable outcomes.
Results and Future Plans:
Pilot Study Results: EPD has achieved an accuracy rate of 67%-98% in detecting bovine TB in cattle during pilot studies, demonstrating its potential in veterinary diagnostics.
Ongoing Development: The company continues to gather and analyze data to improve the accuracy of EPD and expand its applications to other pathogens and settings.

EPD Technologies aims to revolutionize pathogen detection, making healthcare more efficient and better prepared for future epidemics and pandemics. By providing rapid, non-invasive, and remote diagnostic capabilities, EPD has the potential to transform how pathogens are detected and managed in both human and veterinary medicine.